HIV Drug Approvals Lift Hopes Amid Missed UN Targets
The recent approvals of long-acting HIV injections promise to lighten the load of HIV sufferers…
The recent approvals of long-acting HIV injections promise to lighten the load of HIV sufferers…
A monthly two-drug injection developed by the GSK spinoff ViiV Healthcare has been approved for…
Update (06/12/2019): Following the phase III failure of its immunotherapy drug for colorectal cancer in…
The UK company ViiV Healthcare will begin a phase IIa trial of an antibody licensed…
An experimental HIV therapy being developed by GSK spinoff ViiV Healthcare in partnership with Janssen…
A first-in-class HIV treatment developed by the UK company ViiV Healthcare has suppressed the virus…
CRISPR technology offers the promise to cure any human genetic disease. Which are the candidates…
The two-drug pill Dovato, developed by the UK company ViiV Healthcare, has been approved as…
DelSiTech is a Finnish company developing injectable silica gel implants that release drugs slowly over…
Vaccines are humanity’s biggest achievement against infectious diseases. But could they defeat HIV, a particularly…
Update (01/10/2019): The scientists behind the study have declared that the results were based on…
Update (04/04/2019): ViiV Healthcare's two-drug HIV treatment, Juluca, has successfully suppressed the HIV virus for…